Why is Ford’s stock falling after SUV recall?
How will Trump's plan to fire Fed Chair affect markets?
What impact will new trade tariffs have on US economy?
Why did ASML warn of no growth in 2026?
How are Trump’s tariffs influencing US inflation trends?
What caused Renault’s shares to plunge recently?
Why is Nvidia increasing chip sales to China?
Johnson & Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance
benzinga.com/markets/earnings/25/07/46440395/johnson-johnson-lifts-annual-forecast-after-strong-cancer-drugs-medtech-performance
Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year over year, beating the consensus of $2.68.
The pharmaceutical giant reported sales of $23.74 billion, up 5.8% year over year and beating the consensus of $22.85…
This story appeared on benzinga.com, 2025-07-16 12:41:42.